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SUMMARY.-The effect of the administration of L-thyroxine and of methyl-
thiouracil alone, together, in combination with stilboestrol or in the perinatal
period on the induction of cervico-vaginal tumours by weekly local applications
of DMBA was investigated in intact and castrate rats and compared with
carcinogenesis in animals not additionally treated.
In intact rats the rate of sarcoma induction is accelerated by methylthioura-
cil, delayed and reduced by methylthiouracil plus L-thyroxine and delayed by
perinatal injection of either L-thyroxine or methylthiouracil. In castrates
sarcoma induction is accelerated and increased by L-thyroxine, methylthioura-
cil and by combination of either substance with stilboestrol; it is accelerated
but not significantly increased by combined treatment with the thyroactive
compounds.
The incidence of epithelial neoplasms is accelerated and increased in intacts
and in castrates by methylthiouracil. This effect is slightly reduced in intacts
but potentiated in castrates by additional stilboestrol treatment as well as by
administration of L-thyroxine plus methylthiouracil.
The incidence of sarcomas is significantly greater in intact than in spayed
rats not additionally treated, greater in castrates than in intacts given
L-thyroxine ± stilboestrol and not significantly different in intacts and cas-
trates with anyofthe other additional medications. For epithelial tumours the
incidence is low and similar in both groups without additional treatment,
greater in spayed than intact animals given methylthiouracil plus stilboestrol
or plus L-thyroxine.
The influence of the thyroactive compounds on the induction of epithelial
and sarcomatous tumours is not correlated with their effect on gain in body
weight nor on growth of the stroma and of the epithelium of the vagina, cervix
and uterus. Changes induced in the thyroid gland and the hypophysis are not
correlated with those on carcinogenesis.
Central and local factors may account forthe differential response in carcino-
genesis of intacts and castrates as well as of the epithelial and connective tissue
of the cervico-vaginal tract to medication with thyroactive compounds.
THIS investigation was undertaken for two reasons:
(1) Previous experiments using oestrogens, testosterone, progesterone, corti-
sone have shown that the hormonal effects on carcinogenesis do not parallel those
on the normal target organs. Metabolic rather than specific hormonal actions on
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normal target organs may be responsible for the discrepancy in the influence of
endocrines on normal tissues and carcinogenesis in them. Thus the goitrogen
methylthiouracil which slows down growth of the body, may retard, while its
antagonist L-thyroxine may promote carcinogenesis.
(2) There are contradictory reports that the thyroid in man and animals
influences incidence and growth rate of carcinomas (Wilkins and Morton, 1963).
The geographical distribution of cancer appears to be correlated with the incidence
of goitres (Spencer, 1954); thyroid anomalies at post-mortem are 4 times more
frequent inpatients with cancer thanin those dyingfrom other diseases. Adminis-
tration of L-thyroxine has been reported to inhibit the induction and growth of
sarcoma 180 (Williams and Williams, 1965) and ofDBA-induced sarcomas (Bather
and Franks, 1952) in mice, while thyroidectomy or feeding a goitrogen has been
found to decrease the incidence of breast tumours in mice and rats (Vazquez-
Lopez, 1949; Dubnik, Morris and Dalton, 1950; Jull and Huggins, 1960; Helfen-
stein, Young and Currie, 1962; Newman and Moon, 1968). The action of the
thyroid and ofthyroxine administration has been attributed to restriction of food
intake, to the restriction ofanaerobic respiration and to inhibition ofdedifferentia-
tion of carcinogenic tissue. If L-thyroxine has a similar action on the induction
of cervico-vaginal tumours, inhibition of carcinogenesis may result. There are,
however, reports that thyroidectomy like administration ofL-thyroxine have only
a minimal effect on the induction and growth of breast cancers in rats and mice
(Jull and Huggins, 1960; Wilkins and Morton, 1963) and that this action is
mediated through the effect on body weight (Gruenstein, Meranze, Acuff and
Shimkin, 1968).
Castration inhibits and retards the appearance of sarcomas in the cervix and
vagina of rats painted once weekly with DMBA (Glucksmann and Cherry, 1958).
Continuous treatment with oestradiol or with stilboestrol restores the female
genital tract from the atrophic castrate to the normal status, but does not enhance
the induction of sarcomas. In fact in intact animals oestrogens inhibit the induc-
tion of tumours (Glucksmann and Cherry, 1968). On the other hand, adrenalec-
tomy, or the administration of cortisone, pelvic or whole body irradiation of
spayed rats does not alter the atrophic status of the female genital tract, but
accelerates and increases the induction of sarcomas even beyond the rate obtained
in intact rats treated with the carcinogen only (Cherry and Glucksmann, 1960).
Intermittent administration ofstilboestrol in doses insufficient to alter the castrate
status of the vagina, cervix and uterus greatly accelerates and increases the
induction of cervico-vaginal tumours and so does cholesterol. Thus stimulation
of growth in the normal female genital tract by various hormones and other
substances does not lead to increased carcinogenesis, nor is enhanced carcinogenesis
paralleled by growth of the normal target organs.
On the other hand, castration causes atrophy of the epithelium and stroma of
the cervico-vaginal tract and reduces the response to carcinogenic stimulation.
Furthermore sarcomas predominate in intact and castrate rats treated with
DMBA (9,10-dimethyl-1,2-benzanthracene) only. Some additional medications
such as cholesterol, testosterone or intermittent administration of stilboestrol to
castrates and of testosterone or progesterone to intact rats increase the incidence
ofepithelial tumours. In castrates testosterone and intermittent stilboestrol also
promote the appearance of sarcomas while in intact animals testosterone at least
delays their appearance. Thus the action of the various hormones on carcino-
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genesis is not correlated with their specific effects on the female genital tract,
though there is an obvious connection in the case of castration. The connection
is also evidenced by the fact that vulval tumours in intact and castrate rats
treated by these additional means show only a slight response compared with
those in the cervico-vaginal tract.
To find out whether metabolic effects of hormones might explain the differen-
tial action on normal tissues and those subjected to carcinogenic stimulation,
modifications of metabolism, of immune responses and of central regulatory
mechanisms by the pituitary and hypothalamus have been and are being investi-
gated. The present report is concerned with the action of the goitrogen methyl-
thiouracil and of L-thyroxine administered to adult intact and castrate rats (a)
alone, (b) together, or (c) in combination with stilboestrol at the same time as
DMBA, and (d) before DMBA in the perinatal period. Initially we expected that
methylthiouracil might slow down or inhibit tumour induction in intact rats and
that L-thyroxine might promote it in castrates. The experiments revealed,
however, that methylthiouracil in spite ofits inhibitory action on growth promotes
the induction of sarcomas and of epithelial tumours in spayed as well as in intact
animals, while L-thyroxine has only a minimal effect on tumour induction in
intacts, but greatly stimulates the incidence of sarcomas in castrates.
MATERIALS AND METHODS
Hooded rats of the Lister strain, random bred in this laboratory as a closed
colonysince 1940, were usedforthe experiments which extendedovera periodfrom
1955 to 1967. The rats were housed 7 to a cage and given water and food pellets
ofMRC-diet 86 ad libitum. In most ofthe experiments the thyroactive substances
or stilboestrol were dissolved and administered in the drinking water. Only
animals surviving for at least 100 days were considered at risk and the number of
rats in the various treatment groups are given in Table I.
TABLE I.-Treatment Groups, Number of Rats at Risk, Duration of Experiment,
Average Diameter of Uterine Horns, and Incidence of Cervico-vaginal Sarcomas
Treatment groups No. at Duration of Diameter of Sarcomas
(additional treatment) risk experiment uterine horns % + S.E.
(days)
None . 43 . 382 . 1*20* . 72± 6 85
36 . 406 . 0 33 . 25± 720
L-thyroxine . 43 . 388 . 1'20 . 65± 7i28
61 . 322 . 032 . 92± 3-48
Methylthiouracil 9 . 42 . 328 . 100 . 77+ 650
40 . 323 . 029 . 90± 4-75
Both V * 21 . 336 . 1.01 . 29+ 9 90
21 . 304 . 0*28 . 48±10*90
L-thyroxine perinatally 9 . 25 . 328 . 1-03 . 36+ 9-60
Methylthiouracil perinatally 9 . 21 . 322 . 1-12 . 38+10 60
Stilboestrol 9 . 21 . 329 . 1.00 . 14+ 7-60
38 . 396 . 1-01 . 26± 7 10
Stilboestrol + L-thyroxine 9 . 20 . 373 . 1-20 . 55+11-13
19 . 300 . 0-79 . 844 841
Stilboestrol + Methylthiouracil 9 . 21 . 325 . 1.00 . 62+10-60
19 . 370 . 0.72 . 74+10 07
Oestradiol perinatally 9 . 25 . 570 . 0-98 . 32+ 9 30
* A diameter of 1.0 = 1
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Bilateral ovariectomy was performed with a dorsal approach under ether
anaesthesia on rats aged 6 to 8 weeks. Carcinogenic treatment with a 1%
solution in acetone of9,10-dimethyl-1,2-benzanthracene (DMBA, Koch Light Ltd.)
was started when intact and castrate animals were 2-3 months old or at the age
of about 4 months when thyroactive substances were given for 70 days before
starting intravaginal painting. The vagina was stretched open by dorsal flexion
ofthe tail; the solution was applied by means ofa cotton wool swab mounted on a
thin wire rod and distributed through a rotary motion over the cervix, vagina and
introitus. This procedure was repeated at weekly intervals for the life span ofthe
animals.
L-thyroxine sodium B.P. (Eltroxin, Glaxo) was added to the drinking water
(1 mg./1000 ml.) giving a daily dose per rat of approximately 20 jtg. One group
each of intact and castrate animals were treated additionally with 25 jtg. of the
hormone once weekly by intramuscular injection.
Methylthiouracil (B.D.H. 1 g./1000 ml.) was administered in the drinking water
in a daily dose ofabout 20 mg. per rat.
Stilboestrol B.P. was given in the drinking water in a concentration of 0*1 mg./
1000 ml. thus dosing each rat with about 2 ,tg. per day.
Combined treatments.-When two of the above substances were administered
simultaneously in the drinking water the concentration of each solution was
adjusted to arrive at the same dose as when each compound was given separately.
Perinatal treatments.-Rats were injected subcutaneously within 24 hours of
birth either with 1 /ig. of L-thyroxine sodium or 500 ag. of methylthiouracil and
the same dose was repeated after 24 hours.
Some groups of intact and castrate females treated with thyroid hormone or
the goitrogen were marked and weighed individually at weekly or fortnightly
intervals to determine the effect on body growth.
All rats were examined at weekly intervals and sick animals or those with
clinical signs of vulval or vaginal tumours were killed and a post-mortem per-
formed. In addition to the organs of the genital tract from ovary to vulva the
following tissues were taken for histological examination: pituitary, thyroid,
thymus, lungs, liver, spleen, kidneys, adrenals, intestine, mesenteric, lumbar and
inguinal nodes. The material was fixed in Zenker-acetic or Bouin's fluid, dehydra-
ted, embedded in paraffin wax and sectioned at 6 or 8 It depending on the organ;
the endocrine glands were sectioned serially. Sections were stained with haema-
toxylin-eosin, carmalum-orange G-aniline blue, Van Gieson, Southgate's muci-
carmine or the periodic acid-Schiff technique (PAS) after diastase digestion.
RESULTS
Effects of thyroactive compounds on normal tissues
Genital tract.-The administration of thyroactive substances either alone or in
combination to adult rats or separately in the perinatal period has no effect on the
normal histology of the ovaries; ova, primordial, Graafian and atretic follicles as
well as corpora lutea are present. Additional treatment with the dose of stil-
boestrol used does not materially affect the histology nor does it cause ovarian
abscesses.
Castration causes atrophy of the vaginal epithelium and reduces the width of
the stroma ofthe uterus and ofthe vagina to 40% and 48% respectively ofthat in
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intact animals (Glucksmann and Cherry, 1958). The volume of all these target
tissues is restored to intact proportions by additional weekly treatment ofcastrates
with 3 ,ug of oestradiol monobenzoate i.m. or 14 ,tg. of stilboestrol per os. In the
present experiments uterine measurements show that the thyroactive substances
alone, in combination or perinatally have no such effect and the uterus remains
atrophic (Table I). On the other hand, in castrates methylthiouracil as well as
thyroxine inhibit to some extent the stilboestrol effect on the uterus (Table I).
Squamous metaplasia of the endometrial epithelium and the glands is not
induced by the administration of thyroactive compounds. The changes in the
vulval skin are identical with those described below.
Skin. Methylthiouracil causes loss of hair and after prolonged administration
a fairly generalized alopecia. Intact and castrate females appear to be affected
equally even though castration like methylthiouracil causes aplasia or hypoplasia
of the hair follicles. The skin in such animals assumes a yellowish colour as a
result of carotinaemia. A single topical application of L-thyroxine to a bald area
of skin in goitrous rats induces temporary regrowth of hair for at least two hair
cycles. Concomitant methylthiouracil and thyroxine administration prevents loss
of hair and the yellow pigmentation but combined treatment with stilboestrol and
the goitrogen does not. No abnormal skin and hair changes occur in rats treated
perinatally with methylthiouracil.
Thyroid gland.-Methylthiouracil causes marked enlargement of both lobes
and of the isthmus of the thyroid; goitres appear in all intact and castrate rats
thus treated for 114 to 388 days. The lobes are not always equally eniarged and
the size of the goitres varies not necessarily with the duration of the treatment
period. Histologically thepredominant change isdiffusehyperplasiaofthefollicles
and hypertrophy of the follicular cells with depletion of colloid giving a solid
columnar pattern. In some instances cystic or papillary cystic nodules containing
colloid secretion occur within the goitrous gland. The thyroid tumours invade the
capsule ofthe gland and surrounding fat quite frequently and sometimes metasta-
size to the lungs. Additional treatment with stilboestrol does not prevent the
formation of goitres in either intact or castrate animals (Table II). Combined
methylthiouracil and thyroxine administration reduces the incidence of goitres
but colloid secretion is often irregular, the gland is slightly enlarged and some
goitres occur after about 40 weeks.
L-thyroxine sodium does not appear to alter the histological structure of the
gland nor to affect the secretion of colloid. In both intact and castrate animals
the gland shows larger peripheral and smaller central follicles which is typical for
the rat's thyroid. Additional treatment with stilboestrol slightly inhibits secre-
tory activity especially in intacts and this may be correlated with changes in the
pituitary to be described below.
The thyroid gland of adult rats shows similar changes when either of the
thyroactive substances are injected perinatally. Histologically the gland has a
solid and compact appearance with reduced secretory activity although goitres
do not occur even with methylthiouracil treatment.
Microscopical solid follicular adenomas have been found in the thyroids of a
few animals in most experimental groups. Similar adenomas occur in control
intact and castrate rats of our colony (Glucksmann and Cherry, 1968) and none
of the treatments in the present series of experiments has altered their incidence.
They are included as tumours of the thyroid in Table II.
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TABLE II. Incidence of Thyroid and Pituitary Tumours and of Leukaemia
Treatment groups Tumours of:
(additional treatments) Thyroid Pituitary Leukaemia
None * 2 .2
3 . 0 . 11
L-thyroxine . 5 12 2
0 . 2 . 3
Methylthiouracil 100 2 2
100 . 2 . 0
Both S. 29 5 . 19
14 . 0 . 10
L-thyroxine perinatally 12 . 4 12
Methylthiouracil perinatally S 33 10 14
Stilboestrol . 10 0 0
0 16 0
Stilboestrol + L-thyroxine Y 0 5 5
5 0 0
Stilboestrol + Alethylthiouracil 9 . 100 5 0
100 . 0
Oestradiol perinatally 16 8 0
Pituitary. The anterior lobe enlarges after castration and contains a very
large number of hypertrophied gonadotrophs as well as of castration cells. The
thyroactive substances have no effect on the gonadotrophs and additional stil-
boestrol treatment fails to prevent enlargement of the gonadotrophs or the
appearance of castration cells. Enlargement of the pituitary occurs also after
methylthiouracil administration and this is accompanied in both intacts and
castrates by the appearance ofnumerous thyroidectomy cells with very prominent
and coarse PAS-positive granules. In both intact and castrate rats given
L-thyroxine alone thyrotrophs are found although they are probably less promi-
nent with smaller and more faintly stained granules. In intact females treated
concomitantly with stilboestrol and L-thyroxine the thyrotrophs are more promi-
nent than normal and often contain rather coarse PAS-positive granules not unlike
the thyroidectomy cells. Their appearance may be related to the inhibition of
secretion in the thyroid mentioned above.
Combined thyroxine and methylthiouracil administration to intact or castrate
rats does not prevent the appearance ofthyroidectomy cells although they are less
numerous than with methylthiouracil alone. These pituitary changes may be
correlated with the irregular colloid secretion in the thyroids and the induction of
some goitres. Perinatal treatment with either thyroxine or the goitrogen has no
obvious effect on gonadotrophs or thyrotrophs.
Adenomas have been observed in the pituitary of some rats in most of the
experimental groups but, as with the thyroid, their incidence is similar to that in
our intact and castrate control series (Table II). Some adenomas are very
vascular, and replace most of the gland; others are solid, circumscribed and show
variation in cell and nuclear size and mitotic activity. Some of their cells can be
identified as eithergonadotrophs orthyrotrophs by their PAS-positive granulation.
Adrenals.-In rats treated with methylthiouracil alone the glands have an
abnormal dark brown colour. Solid adenomas occur in the cortex of some rats
but their incidence is not correlated with any particular form oftreatment nor does
it differ from that in our control series.
Breast tumours do not occur in spayed females ofour colony and none have been
induced by any of the additional treatments. In intact controls the incidence of
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breast tumours has varied from 7% in 1955 to 10% in 1964. In the present series
fibroadenomas ofthe breast have been found in 3 intact rats given L-thyroxine.
Leukaemia.-The incidence of leukaemia in the present experiments has
varied from 0 to 19% (Table II) and falls within the control range as does the time
when the disease becomes manifest. There is no evidence that DMBA application
nor additional treatment with thyroactive substances and stilboestrol increases
the incidence ofleukaemias.
Effects of hormonal treatments on gain in body weight
Since some ofthe action ofthyroactive substances on carcinogenesis have been
attributed totheir effect on bodyweight (Jull and Huggins, 1960; Gruenstein et al.,
1968), the weights ofratsgivenL-thyroxine or methylthiouracil have beenrecorded
for the duration ofthe experiment. In Fig. 1 the average weights for 4 groups of
21 animals each are contrasted. The initial weight and age of the rats varied to
some extent and the growth curve in young animals is very steep as for instance
in intacts given L-thyroxine. Rats on methylthiouracil remain small while those
on L-thyroxine continue to grow. The gain in body weight is not correlated with
the incidence ofinduced tumours, since these are of the same order in intacts and
in castrates treated with thyroactive compounds (Fig. 2 and 8; Table III).
If the differences in initial weight are corrected by calculating the percentage
increase in weight from an average of 190 + 10 g. for a subsequent period of 28
weeks, the total gain in L-thyroxine treated rats is around 40% and in females
with goitres only 14%. Additional data on the relation ofbody weight to induc-
tion oftumours obtained in as yet unpublished experiments are given in Table III,
and show that tumour induction does not vary with percentage gain in weight.
E
E
C:
- Intacts
Castrates
Weeks
FIa. 1.-Average weight of intact and castrate rats given L-thyroxine (L) or methylthiouracil (M).
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TABLE III.-Average Gain in Body Weight up to 190 ± 10 g. andfor 28 Weeks after
Reaching this Level
Papillomas +
Additional Initial (a) (b) Sarcomas carcinomas
treatment weight weeks/% % % ± S.E. % ± S.E.
L-thyroxine . 124 . 4/13 . 35 . 65+ 7
-28 . 0
168 . 2/6 5 45 . 92+ 3-48 . 16± 4.7
Methylthiouracil S . 180 . - . 14 . 77 6 50 45 7-7
189 . - . 14 . 90+ 4*75 . 30± 7 2
Insulin . 197 . . 24 . 52±10-4 9+ 60
117 . 4/15 45 . 85+ 8*0 50±11*2
Alloxan 124 . 16/3-3 20 . 65+ 94 19+ 77
(sugar in urine) g 156 . 4/5.5 . 43 95± 49 75+ 97
(urinenegative 9 . 161 . 4/4.5 . 28 46±129 . 7+ 66
forsugar) g . 197 . 47 94+ 5 9 25+108
Growth hormone S . 189 . - 48 . 4310-8 . 28+ 9.8
-g . 137 . 2/18 . 78 55+11 1 . 40±11*0
(a) Number of weeks and percentage gain per week to reach an average weight of 190 + 10 g.
(b) Percentage gain in 28 weeks after reaching an average weight of 190 + 10 g.
Thusthe animalsreceivinggrowthhormone*growfastestbuthave alowerincidence
of sarcomas and of epithelial tumours than the methylthiouracil treated animals
at the other end ofthe growth scale. The highest incidence of all tumours occurs
in diabetic castrates whose increase in body weight is very much like that of
castrates given L-thyroxine.
The initial gain in weight, i.e. until an average of 190 + 10 g. is reached,
appears to vary with the additional treatment rather than the level of the initial
weight: in diabetic intacts of 124 g. it is only 3-3% while in L-thyroxine treated
intacts of the same initial weight it is 13% per week; in insulin treated castrates
of 117 g. it is 15% compared with 18% in castrates of 137 g. treated with growth
hormone.
From the 190 g. level castrates gain twice as much as intacts receiving the
same treatment, except that there is no difference in weight gain between intacts
and castrates given the goitrogen and the difference is smaller in the thyroxine
treated animals. Greater deposition of fat in castrates accounts to some extent
for the difference in weight. With the exception of epithelial tumours and the
weight increase in methylthiouracil medicated rats, the incidence ofboth sarcomas
and epithelial tumours, and the gain in body weight, is always greater in castrates
than in intacts.
Effects on carcinogenesis
The histogenesis and histology of sarcomas and of epithelial tumours induced
by DMBA in the cervico-vaginal tract has been described in some detail in a
previous publication (Glucksmann and Cherry, 1970) and the same range of
tumours has been found in the present experiments. The additional treatment
with thyroactive substances has not modified the type of induced tumours nor
the process of histogenesis, though it has affected the rate of carcinogenesis
particularly in castrates. As pointed out previously (Glucksmann and Cherry,
* A preparation of bovine growth hormone was kindly presented by Dr. A. E. Wilhelmi of Emory
University, Atlanta, Georgia, on behalfofthe Endocrinology Study Section ofthe National Institutes
of Health, Bethesda, U.S.A.
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1968), experiments repeated at intervals of up to 10 years have yielded the same
results as regards tumour induction.
Cervico-vaginal sarcomas. The effects of concomitant DMBA treatment with
either L-thyroxine or methylthiouracil or with both substances are illustrated in
Fig. 2. In intact rats L-thyroxine has little effect on the rate of appearance of
sarcomas, while methylthiouracil shortens the induction period for the first
tumours, but does not affect the subsequent accumulation of neoplasms which
parallels that of intact rats not additionally treated (H20). The combined
treatment prolongs the interval before the first sarcomas arise, but does not affect
the rate of tumour induction. Methylthiouracil like L-thyroxine shortens the
induction periodofsarcomas in castrates and greatly increases the rate atwhich the
tumours appear. This effect is significant in comparison with castrate as well as
intact rats treated by DMBA only. The combined treatment still promotes
sarcoma formation in castrates, but not to the same extent as does either treatment
alone.
- Intact Rats
-- Castrate Rats
HA0 Rats treated with
D M B A only
200 400
Days
Fi(c. 2.-The induction of cervico-vaginal sarcomas in intact and castrate rats given
methylthiouracil, L-thyroxine or both after weekly applications of DMBA.
The analysis for the three separate experiments of treating the rats with
L-thyroxine added to the drinking water alone, or supplemented by intramuscular
injections or started 70 days before DMBA painting is given as age-specific
induction rates in Fig. 3. There is no significant difference between the various
forms of treatments in either intact or castrate rats.
Fig. 4 gives a similar analysis of experiments with methylthiouracil, showing
again little difference between treatments started 70 days before and at the same
time as DMBA painting. The slight accelerating effect in intacts and the marked
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Fim. 3.-Age-specific induction rates of cervico-vaginal sarcomas by weekly applications of DMBA
in intact and castrate rats given L-thyroxine (L), i.e. the percentage of rats with tumours during
consecutive 100 day periods plotted at the 50 day interval.
250 500
Days
FIG. 4.-Age-specific induction rates of cervico-vaginal sarcomas by weekly applications of
DMBA in intact and castrate rats given methylthiouracil (M).
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acceleration and promotion of tumour induction in castrates are clearly demon-
strated. The age-specific induction rates for additionally treated intacts are very
close to those for castrates, while for L-thyroxine the intacts lag behind the
castrates (Fig. 3).
The differences between intacts and castrates without additional treatment are
significant at the 95% confidence level and the same holds true for L-thyroxine
though this time in favour of castrates. The total incidence ofsarcomas (Table I)
is ofthe same order in intact and castrate rats treated with the goitrogen. Com-
pared with animals not additionally treated the combined treatment decreasesand
slows down tumour formation in intacts but accelerates and slightly increases it in
castrates. The final difference is not significant at the 95% confidence level but
the duration of experiments with castrates not additionally treated exceeds by
100 days that with both thyroactive substances. Compared with the effect of
either methylthiouracil or L-thyroxine alone, the combined treatment produces
significantly fewer sarcomas in intacts and castrates for the same period of obser-
vation. The combination of thyroactive substances does not cancel out the
separate effects, since there is a significant depression of sarcoma induction in
intacts and a real acceleration in castrates (Fig. 2).
To test whether the promotion of growth of the tissues of the cervico-vaginal
tract by oestrogens affects the induction of tumours by DMBA, stilboestrol was
administered continuously to intact and castrate animals also given a thyroactive
compound. Additional stilboestrol alone retards and decreases the incidence of
sarcomas in intacts but has no effect in castrates (Fig. 5). Thus the difference in
sarcoma induction between intacts and castrates disappears after oestrogenic
treatment because ofthe depressing effect in intacts.
Combination of stilboestrol with L-thyroxine causes a very significant increase
and acceleration of sarcoma induction in intacts compared with those given
stilboestrol only, but a slight retardation and decrease compared with rats not
given any additional treatment (Fig. 5). In castrates the combination greatly
E
- Intact
Castrate
Day
Days
300
FiG. 5.-The induction of cervico-vaginal sarcomas by weekly applications of DMBA in intact
and castrate rats given L-thyroxine (L) plus stilboestrol (S).
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increases the incidence and accelerates the appearance of sarcomas as compared
with those given only stilboestrol or no additional treatment. The effect is about
equal to that ofL-thyroxine alone.
In similar experiments with methylthiouracil (Fig. 6) combination with stil-
boestrol greatly increases the incidence of sarcomas in intacts compared with
stilboestrol alone but retards it in comparison with methylthiouracil. A similar
retardation occurs in castrates though there is still a significant increase and
acceleration in comparison with rats given stilboestrol or no additional medication.
cu
60
a4
CD
40
E
20
- In
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Days
FiGc. 6.-The induction of cervico-vaginal sarcomas by weekly applications of DMBA in intact
and castrate rats given methylthiouracil (M) plus stilboestrol (S).
The injection of oestradiol in the perinatal period greatly delays and decreases
the incidence of sarcomas following painting with DMBA (Cherry and Glucks-
mann, 1968). To see whether treatment with thyroactive compounds in the
perinatal period modifies the response to carcinogens because of changes in the
pituitary and hypothalamus, experiments with these substances were performed.
The injection of L-triiodothyronine in the perinatal period has been reported to
affect the growth ofrats, of their thyroid and the formation of acidophiles in the
pituitary (Eayrs and Holmes, 1964). The results for treatment with methyl-
thiouracil and L-thyroxine on sarcoma induction are the same (Fig. 7): compared
with intact rats the rate is slowed down though not to the same extent as in
oestrogenized animals. In all three instances the level of sarcoma incidence is
close to that of castrates not additionally treated.
To sum up: compared with intact rats without additional treatment the rate
of sarcoma induction is accelerated by the administration of methylthiouracil,
delayed by the injection ofmethylthiouracil or L-thyroxine in the perinatal period
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Fia. 7. The induction of cervico-vaginal sarcomas by weekly applications of DMBA in rats
treated perinatally with methylthiouracil (M) or L-thyroxine (L).
and delayed and significantly reduced by stilboestrol and by the administration
of methylthiouracil plus L-thyroxine. Compared with castrates without addi-
tional treatment the induction of sarcomas is accelerated and increased by
L-thyroxine, methylthiouracil and by either substance combined with stilboestrol;
it is accelerated by combined treatment with methylthiouracil plus L-thyroxine
and not changed by stilboestrol alone. The incidence of sarcomas is significantly
greater in intacts than in castrates without additional treatment, greater in
castrates than in intacts treated with L-thyroxine + stilboestrol and not signifi-
cantly different in intacts and castrates after administration ofmethylthiouracil +
stilboestrol, methylthiouracil plus L-thyroxine and by stilboestrol alone.
Cervico-vaginal carcinomas and papillomas. As regards the promotion or
inhibitionbythyroactive compounds, carcinomas andpapillomas can be considered
together because on the whole the frequency of carcinomas increases with that of
papillomas and follows it. The proportion of papillomas to carcinomas in the
various experiments is given in Table IV. Without additional treatment the
incidence of epithelial tumours is the same in intacts and castrates and amounts
to about 10% (Fig. 8). Methylthiouracil accelerates and increases the incidence
of epithelial neoplasms in castrates and intacts, while L-thyroxine does not
materially alter the yield in either though there is a slight acceleration in tumour
formation in castrates and an inhibition in intacts. Combined treatment with the
thyroactive substances in spayed females potentiates the promoting effect of
either alone with statistically significant differences in yield from either separately.
In intact animals the effect of combined treatment is intermediate between that of
either substance alone, and not significantly different from that ofanimals without
additional medication.
As regards epithelial tumours methylthiouracil combined with stilboestrol
potentiates the action of DMBA in spayed rats, but slightly reduces the methyl-
thiouracil effect in intact animals (Fig. 9). Stilboestrol added to L-thyroxine
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TABLE IV.-Percentage of Rats with Cervico-vaginal Papillomas and Carcinomas
Additional treatment
None 9
L-thyroxine 9
Methylthiouracil 9
Both 9
L-thyroxine perinatally 9
Methylthiouracil perinatally 9
Stilboestrol 9
Stilboestrol + L-thyroxine 9
Stilboestrol +Methylthiouracil 9
Oestradiol perinatally 9
80u
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Papillomas
5
11
0
14
43
25
14
33
24
5
5
0
10
21
19
42
28
Carcinomas
2
0
0
2
2
5
0
24
0
0
0
0
0
0
10
11
20
Papillomas + carcinomas
% ± S.E.
7+ 3-9
11+ 5-2
0
16+ 4 7
45+ 7 7
30± 7*2
14+ 7 6
57±10-8
24+ 8-6
5+ 4-8
5+ 4-8
0
10+ 6*7
21+ 93
29+ 9 9
53±11*5
48±10-0
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FIG 8.-The induction of cervico-vaginal carcinomas and papillomas in intact and castrate rats
given methylthiouracil, L-thyroxine or both after weekly applications of DMBA.
slightly, but not significantly, promotes carcinogenesis in both groups of rats.
Perinatal injection of either of the thyroactive compounds does not influence the
subsequent induction by DMBA of epithelial neoplasms (Table IV).
If the action of additional medication with thyroactive compounds whether
given alone, in combination or in addition to stilboestrol is compared in intact
andin spayedrats, some interesting andsignificant differences arebrought to light.
Significantly more epithelial tumours are induced in the 160 castrates, i.e. 30% +
3*6, than in the 147 intacts, i.e. 20% ± 3-3. The incidence of papillomas is not
significantly different in the two groups (24% ± 3*4 in castrates and 18% ± 3-2
inintacts), noristhat ofcarcinomas although itrisesbyafactorof3from 2% ± 1*2
in intacts to 6% + 1.9 in castrates. In a similar calculation for sarcomas a
significant difference is found in favour of castrates over intacts: i.e. 82% ± 3.0
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FIG. 9.-The induction of cervico-vaginal carcinomas and papillomas by weekly applications
of DMBA in intact and castrate rats given either methylthiouracil (M) or L-thyroxine (L)
stilboestrol (S).
and 61% ± 4*0 thus reversing the proportion of induced sarcomas without
additional medication, i.e. 25% ± 7-2 for castrates and 72% 6.85 for intacts.
While in intacts the incidence of sarcomas is about the same with and without
additional thyroactive compounds, that in castrates is greatly and significantly
increased by the thyroactive compounds.
Since with DMBA alone the percentage of epithelial tumours induced is very
low in castrates and intacts, it is not possible to demonstrate clearly a decrease
due to additional medication. Thus only no significant change or increase in
proportion are listed in Table V; for sarcomas no change, an increase as well as a
decrease are given. The table indicates clearly the difference between intact and
castrate rats and also the difference in response ofthe epithelial and the connective
tissue to additional medication with thyroactive compounds. In intacts the
incidence of epithelial tumours is increased by methylthiouracil given alone or
combinedwith stilboestrol; there is no increase in sarcomas, but a decrease with the
TABLE V.-Statistically Significant Changes in the Incidence of Epithelial and
Sarcomatous Tunours due to Additional Treatments
Tumours
Epithelial Sarcomatous
N.S. N.S.
N.S.
N.S.
Additional treatments
Intacts Castrates
L-thyroxine ±
stilboestrol
More
Less
More N.S.
L-thyroxine plus
methylthiouracil
Methylthiouracil ±
stilboestrol
More More
N.S. = Change not significant at 95% confidence level.
L-thyroxine ±
stilboestrol
L-thyroxine plus
methylthiouracil
Methylthiouracil +
stilboestrol
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combined administration of methylthiouracil and L-thyroxine. In castrates more
epithelial tumours occur after treatment with L-thyroxine plus methylthiouracil
and with methylthiouracil alone or combined with stilboestrol; sarcomas occur
in the same proportion with the combined thyroactive compounds or are promoted
by either L-thyroxine ± stilboestrol or methylthiouracil ± stilboestrol.
DISCUSSION
The effects of thyroactive compounds on the experimental induction of breast
tumours are equivocal and if present inhibitory (Jull and Huggins, 1960; Helfen-
stein et al., 1962; Newman and Moon, 1968) while they greatly accelerate and
increase the induction of cervico-vaginal neoplasms particularly in castrates. To
some extent this contrast might be attributed to the fact that in spayed rats
tumours at either site occur only rarely (Shay, Harris and Gruenstein, 1952) and
that the action of thyroactive compounds on the carcinogenesis of mammary
tumours has been tested only in intactrats; Methylthiouracil, however, accelerates
and increases the development of epithelial tumours at the cervix also in intact
rats and this suggests that the difference at the two sites is real. Furthermore, the
reduction in weight gain diminishes the incidence of breast tumours whether this
is brought about by restriction of food intake, thyroidectomy (Gruenstein et al.,
1968; Jull and Huggins, 1960) or administration ofpropylthiouracil (Newman and
Moon, 1968). The induction of cervico-vaginal tumours, however, is not affected
by differences in the rate of gain in body weight (Table III) varying from 0.5%o
to 2.4% per week.
There is also no correlation between growth ofthe epithelium and stroma ofthe
cervico-vaginal tract and carcinogenesis induced in them. Oestrogenic stimulation
sufficient to promote growth in the stroma and epithelium of castrates, inhibits
tumour formation in intacts and fails to promote it in castrates. The thyroactive
compounds do not stimulate growth of these normal structures, but in castrates
they increase the incidence of epithelial and sarcomatous tumours, and in intacts
methylthiouracil increases that of papillomas and carcinomas. Stimulation of
growth of the cervico-vaginal tissues by the addition of stilboestrol to the thyro-
active medication tends to delay the formation of sarcomas (Fig. 5 and 6) in
intacts and castrates, though there is a slight tendency to promote the appearance
of epithelial tumours (Fig. 9). While in the oestrous cycle, for instance, growth
ofthe stroma is coordinated with that ofthe epithelium this correlation is disturbed
in carcinogenesis. Treatment by DMBA induces immediately some squamous
hyperplasia in the atrophic castrate epithelium, but no thickening ofthe stroma is
noticed before tumour formation. The preferential promotion by thyroactive
substances of epithelial but not of sarcomatous tumours in intacts is further
evidence of this disturbed relation.
The additional medication with thyroactive compounds produces more sar-
comas faster in castrates than in intacts and this difference is significant with
L-thyroxine ± stilboestrol treatment. Thus formation of connective tissue
tumours in intacts is not maximal. Furthermore, in spayed animals both thyro-
active compounds increase the incidence of sarcomas, but only methylthiouracil
significantly affects that of epithelial tumours.
Thus the effects of thyroactive compounds on growth ofthe body or on that of
the cervico-vaginal tract are not correlated with those on carcinogenesis. The
additional medication may have systemic metabolic or immunological actions.
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The incidence of carcinomas and of sarcomas in additionally treated castrates
exceeds significantly that in intacts and there is a similar advantage in body weight
which is partly accounted for by fat deposition. Without additional medication,
however, castrates have fewer sarcomas than intacts and in rats treated with
growth hormone a striking difference in weight gain between intacts and castrates
is not paralleled by any significant difference in carcinogenesis (Table III). Of
other metabolic changes analysed, neither diabetes nor insulin medication produces
the same effects in intacts and castrates. A specific metabolic action of the
various hormones cannot be exluded but it would have to account for a differential
influence on epithelium and connective tissue as well as on intacts and spayed
animals and for an only equivocal effect on carcinogenesis of the breast and vulva.
A possible immunological action has been found to be unlikely (Cherry and
Glucksmann, 1960). While cortisone or whole body irradiation increases the
tumour incidence in castrates, irradiation inhibits it in intacts presumably because
of its sterilizing effect on the ovary. The effects of whole body exposure to
X-rays and irradiation restricted to the pelvic region are identical in both intacts
and castrates, though immunological competence is reduced much more by whole
body than by partial body irradiation.
The oestrous cycle in rats shows a coordinated sequence of events in the
epithelium and stroma of the uterus and of the cervico-vaginal tract and the
changes are determined locally by the receptors in the tissue reacting to ovarian
and other hormones which in their turn are regulated by the pituitary and hypo-
thalamus. The topical administration of DMBA appears to interfere locally with
the coordination ofthe epithelial and stromal components, i.e. with the activity or
responsiveness of the receptors in these tissues and thus leads to a predominance
of sarcomas over epithelial tumours in intact and pregnant animals (Glucksmann
and Cherry, 1958) as well as in castrates. The cyclical activity of the pituitary
and hypothalamus and with it of the ovary can be modified by the perinatal
treatment of rats with oestradiol or with testosterone (Cherry and Glucksmann,
1968). If such animals are subjected to carcinogenic insults, the appearance of
sarcomas as well as of epithelial tumours is delayed as compared with intact rats
and with rats treated perinatally with either L-thyroxine or methylthiouracil (Fig.
7). The incidence of sarcomas in all the perinatally treated animals is of the same
order and similar to that in castrate rats without additional medication. In
oestrogenized mice and rats, however, more epithelial tumours than sarcomas are
induced and they occur even without carcinogenic treatment (Dunn and Green,
1963; Kimura and Nandi, 1967; Takasugi and Bern, 1964; Cherry and Glucks-
mann, 1968), but not in rats treated perinatally with testosterone, methylthiouracil
or L-thyroxine. In the latter group of animals the age-specific appearance of
sarcomas resembles that in intact animals without additional treatment, while in
oestrogenized rats it follows the pattern for castrates. These findings suggest
that central factors may influence differentially the response to carcinogens of the
stroma and epithelium of the target organ.
The central regulatory mechanism does not appear to be located primarily in
the pituitary since there is no correlation between changes in the basophiles with
the induction rate of either sarcomas or epithelial neoplasms. Thus in castrates
given L-thyroxine concomitantly with DMBA castration cells are present in
impressive numbers in the pituitary and there are more sarcomas than in similarly
treated intacts. Without additional medication, however, a similar difference in
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the incidence of castration cells is associated with a significantly greater per-
centage of sarcomas in intact rats. The incidence of sarcomas and of epithelial
tumours is the same in castrates given either methylthiouracil or L-thyroxine,
though in the former but not in the latter group thyroidectomy cells arefrequent.
No very obvious changes in incidence of gonadotrophs and thyrotrophs appearin
rats treated perinatally with oestradiol, testosterone, L-thyroxine or methyl-
thiouracil though tumour incidence is modified. Some thyroidectomy cells are
found in rats given methylthiouracil plus L-thyroxine and in intacts as well asin
castrates the incidence ofsarcomas is reduced significantly compared with animals
given only one of the thyroactive compounds. On the other hand, epithelial
neoplasms are significantly more frequent in castrates if the compounds are given
simultaneously rather thanseparately butinintacts the difference isnot significant.
Castration appears to affect the central regulatory mechanism and to make it
more responsive to additional hormonal treatments as indicated by the greater
effectiveness of additional medication in castrates than in intacts. Whether the
inhibitory effect of continuous oestrogen administration on the induction of
cervico-vaginal tumours in intact females (Glucksmann and Cherry, 1968) and on
salivary gland tumours in intact male rats (Glucksmann and Cherry, 1966) is due
to an effect on the receptor system ofthe target organs or on the central regulatory
mechanisms cannot yet be decided. Inthe complex effects ofadditional hormonal
treatments on carcinogenesis in various sitesthere may be aninterplay ofthe target
organs with the higher regulatory centres. Though responding to sex hormones
the receptors in the cervico-vaginal tract, the vulva, the breast and salivary glands
may respond differently to stimulation by other hormones and in their feedback
to the higher centres. Thus thyroactive compounds have an only equivocal effect
onthe induction ofbreast cancers and on those ofthe vulva, a promoting action on
those of the cervico-vaginal tract and inhibit carcinomas of the salivary gland in
intact and castrate females (Glucksmann and Cherry, 1966).
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